SNCA and Parkinson disease: Increasing scientific evidence suggests that abnormal α-synuclein aggregation in intracellular insoluble protein inclusions in the brain is involved in the pathophysiology of several neurodegenerative diseases, including Parkinson’s disease, atrophy multisystem disease and dementia with Lewy bodies [57].